Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli

Journal of Infection

Volumn 65, Issue 6, 2012, Pages 584-586

  Tsai, Hsih Yeh ^a,b   Liao, Chun Hsing ^a   Cheng, Aristine ^a,b   Liu, Chia Ying ^a   Huang, Yu Tsung ^a,b   Sheng, Wang Huei ^b   Hsueh, Po Ren ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CARBAPENEM; CEFALEXIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFMETAZOLE; CEFOTAXIME; CREATININE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

AGED; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; BACTERIURIA; BROTH DILUTION; CASE REPORT; COLONY FORMING UNIT; CREATININE BLOOD LEVEL; DISK DIFFUSION; DYSURIA; ECHOGRAPHY; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; KLEBSIELLA PNEUMONIAE INFECTION; LABORATORY TEST; LETTER; MICTURITION DISORDER; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL COUNT; POLYMYOSITIS; PYURIA; RECURRENT INFECTION; URINARY TRACT INFECTION; URINE CULTURE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MINOCYCLINE;

EID: 84869088584     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.09.007     Document Type: Letter

References (7)

1. Arya S.C., Agarwal N. Emergence of tigecycline resistance amongst multi-drug resistant gram negative isolates in a multi-disciplinary hospital. J Infect 2010, 61:358-359.
2. Bader M.S., Hawboldt J., Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 2010, 122:7-15.
3. Geerlings S.E., van Donselaar-van der Pant K.A., Keur I. Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother 2010, 65:2048-2049.
4. Cunha B.A. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (mdr) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis. J Clin Microbiol 2009, 47:1613.
5. Nix D.E., Matthias K.R. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation. J Antimicrob Chemother 2010, 65:1311-1312.
6. Satlin M.J., Kubin C.J., Blumenthal J.S., Cohen A.B., Furuya E.Y., Wilson S.J., et al. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-Resistant Klebsiella pneumoniae from urine. Antimicrob Agents Chemother 2011, 55:5893-5899.
7. Spanu T., De Angelis G., Cipriani M., Pedruzzi B., D'Inzeo T., Cataldo M.A., et al. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2012, 56:4516-4518.